Home › Gastrointestinal Cancers
Gastrointestinal Cancers clinical trials recruiting in the U.S.
70 studies for Gastrointestinal Cancers are recruiting participants at sites across the United States.
Cities with the most studies
- Houston, TX21 studies
- Boston, MA15 studies
- New York City, NY12 studies
- Nashville, TN11 studies
- Los Angeles, CA10 studies
- Arlington, VA8 studies
- Durham, NC8 studies
- Baltimore, MD8 studies
- Dallas, TX8 studies
- Baldwin Park, CA7 studies
- Cincinnati, OH7 studies
- Seattle, WA7 studies
- Aurora, CO7 studies
- Tampa, FL7 studies
- San Antonio, TX7 studies
- Philadelphia, PA6 studies
- Grand Rapids, MI6 studies
- Chicago, IL6 studies
- St. Louis, MO5 studies
- Washington, DC5 studies
- Queens, NY5 studies
- Salt Lake City, UT5 studies
- Indianapolis, IN5 studies
- Santa Monica, CA5 studies
- San Francisco, CA5 studies
- Columbus, OH4 studies
- New Haven, CT4 studies
- San Diego, CA4 studies
- Phoenix, AZ4 studies
- Rochester, MN4 studies
- Omaha, NE4 studies
- Sarasota, FL4 studies
- Sacramento, CA4 studies
- Pittsburgh, PA4 studies
- Mountain View, CA4 studies
- Atlanta, GA4 studies
- Detroit, MI4 studies
- Irving, TX3 studies
- Oklahoma City, OK3 studies
- Scottsdale, AZ3 studies
By state
- Arizona8 studies
- California29 studies
- Colorado10 studies
- Connecticut6 studies
- Florida17 studies
- Georgia6 studies
- Illinois7 studies
- Indiana6 studies
- Kansas5 studies
- Louisiana4 studies
- Maryland13 studies
- Massachusetts15 studies
- Michigan11 studies
- Minnesota6 studies
- Missouri5 studies
- Nebraska5 studies
- New Jersey3 studies
- New Mexico3 studies
- New York14 studies
- North Carolina10 studies
- Ohio14 studies
- Oklahoma3 studies
- Oregon3 studies
- Pennsylvania9 studies
- South Dakota3 studies
- Tennessee14 studies
- Texas26 studies
- Utah5 studies
- Virginia9 studies
- Washington8 studies
- Wisconsin6 studies
Recently updated studies
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Nov 12, 2026 · NCT04847063Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Recruiting
Ages 18 to 99 · All sexes · Updated Nov 12, 2026 · NCT04907643A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07020221Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07283939A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06760819A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06663319Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07539311Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
RecruitingPhase 1/2
Ages 18 to 72 · All sexes · Updated Nov 3, 2026 · NCT03190941Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07124351Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT01313442Avera Cancer Sequencing and Analytics Protocol (ASAP)
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT05142033Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT07529808Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT06582017EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
Recruiting
Ages 18 to 100 · All sexes · Updated Oct 20, 2026 · NCT06340620A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT06885034Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT06855524Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2026 · NCT07222800The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT04700527A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07544589A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07218926DESTINY-PANTUMOUR04
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05274048GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
RecruitingEarly phase 1
Ages 18 to 99 · All sexes · Updated Sep 18, 2026 · NCT07627191From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.